The Interaction of Heptakis (2,6-di-O-Methyl)-β-cyclodextrin with Mianserin Hydrochloride and Its Influence on the Drug Toxicity.
Sylwia Belica-PachaMagdalena MaleckaMateusz DaśkoKatarzyna MiłowskaMaria BryszewskaGrazyna BudrynJoanna OraczBartłomiej PałeczPublished in: International journal of molecular sciences (2021)
One tetracyclic antidepressant, mianserin hydrochloride (MIA), has quite significant side effects on a patients' health. Cyclodextrins, which are most commonly used to reduce the undesirable features of contained drugs within their hydrophobic interior, also have the potential to alter the toxic behavior of the drug. The present paper contains investigations and the characteristics of interaction mechanisms for MIA and the heptakis (2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD) system, and evaluated the effects of the complexation on MIA cytotoxicity. In order to assess whether there was an interaction between MIA and DM-β-CD molecules, isothermal titration calorimetry (ITC) have been chosen. Electrospray ionization mass spectrometry (ESI-MS) helped to establish the complex stoichiometry, and circular dichroism spectroscopy was used to describe the process of complex formation. In order to make a wider interpretative perspective, the molecular docking results have been performed. The viability of Chinese hamster cells were investigated in the presence of DM-β-CD and its complexes with MIA in order to estimate the cytotoxicity of the drug and the conjugate with the chosen cyclodextrin. The viability of B14 cells treated with MIA+DM-β-CD is lower (the toxicity is higher) than with MIA alone, and no protective effects have been observed for complexes of MIA with DM-β-CD in any ratio.
Keyphrases
- mass spectrometry
- molecular docking
- capillary electrophoresis
- ms ms
- public health
- end stage renal disease
- nk cells
- ionic liquid
- induced apoptosis
- ejection fraction
- multiple sclerosis
- mental health
- chronic kidney disease
- major depressive disorder
- staphylococcus aureus
- peritoneal dialysis
- adipose tissue
- drug delivery
- cancer therapy
- patient reported outcomes
- skeletal muscle
- insulin resistance
- weight loss
- health promotion